Open surgical bypass is the gold standard, but endovascular therapies may provide value for high-risk patients with long femoropopliteal lesions.

The cardiologist at the head of an influential CDC panel sees serious problems with modern vaccine policies. While many experts seem to disagree, one organization has jumped to his defense. 

Abbott first warned the public about this problem in November. Now, for the second time in less than a month, the FDA is providing additional details. 

The annual rankings, based on survey responses and interviews, include a fresh look at some of most important tools in cardiovascular care. 

Nina Goodheart, the president of Medtronic’s structural heart and aortic business, has announced her retirement. 

The interventional treatment of tricuspid valve disease has evolved in recent years thanks to new research and critical FDA approvals. Cardiologist Ryan Kaple, MD, reviewed this trend for a new video interview.

ADP offers care teams multiple benefits not seen with traditional wire-based physiologic assessments. A roundtable of 17 expert clinicians discussed the topic at length, and their findings were used to develop a new manuscript published in JSCAI.

Badhwar is a longtime STS member and world leader in robotic technologies. In fact, he and his team recently launched a 40-part video series to help teach other clinicians about robotic-assisted cardiac surgery.

There is a risk of users making adjustments during treatment that are unnecessary. The FDA is still evaluating the issue at this time.